| Item |
Cat. No. |
Species |
Species Reactivity |
Type |
Application |
| Anti-CK14+17 mAbs [8.7/21](MABL-1216) |
MABL-1216 |
Engineer |
Human |
| Anti-CK mAbs [AE3](MABL-1215) |
MABL-1215 |
Engineer |
Rat, Human, Mouse |
| Anti-Citrullinated collagen type II mAbs [ACC4](MABL-1214) |
MABL-1214 |
Engineer |
Human, Mouse |
| Anti-Citrullinated collagen type II mAbs [ACC1](MABL-1213) |
MABL-1213 |
Engineer |
Cow, Human, Mouse |
| Anti-Citreoviridin mAbs [5A10](MABL-1212) |
MABL-1212 |
Engineer |
Penicillum citreoviridin |
| Anti-Cisplatin modified DNA mAbs [CP9/19](MABL-1211) |
MABL-1211 |
Engineer |
Species independent |
| Anti-Circumsporoziote protein mAbs [2A10](MABL-1210) |
MABL-1210 |
Engineer |
Plasmodium falciparum |
| Anti-CIAO1 mAbs [RAB-C492](MABL-1209) |
MABL-1209 |
Engineer |
Human |
| Anti-Chronic lymphocytic leukemia mAbs [Lym-2](MABL-1208) |
MABL-1208 |
Engineer |
Human |
| Anti-Cholera enterotoxin B subunit mAbs [TE33](MABL-1207) |
MABL-1207 |
Engineer |
Vibrio cholerae |
| Anti-Cholera enterotoxin B subunit mAbs [A9 (LCTA9)](MABL-1206) |
MABL-1206 |
Engineer |
Vibrio cholerae |
| Anti-Chloramphenicol mAbs [sdsFvCAP](MABL-1205) |
MABL-1205 |
Engineer |
Species independent |
| Anti-Chloramphenicol mAbs [Chl-VHH (Chl‐B2F47W)](MABL-1204) |
MABL-1204 |
Engineer |
Species independent |
| Anti-Chloramphenicol mAbs [Chl-D1](MABL-1203) |
MABL-1203 |
Engineer |
Species independent |
| Anti-Chloramphenicol mAbs [10A3B6E](MABL-1202) |
MABL-1202 |
Engineer |
Species independent |
| Anti-Chlamydia trachomatis antigens mAbs [aCt1](MABL-1201) |
MABL-1201 |
Engineer |
Chlamydia trachomatis |
| Anti-Chlamydia trachomatis antigen mAbs [aCt2](MABL-1200) |
MABL-1200 |
Engineer |
Chlamydia trachomatis |
| Anti-Chitinase-3-like protein 1 mAbs [L3H4](MABL-1199) |
MABL-1199 |
Engineer |
Human |
| Anti-Chitinase-3-like protein 1 mAbs [4A12](MABL-1198) |
MABL-1198 |
Engineer |
Human |
| Anti-Chitinase-3-like protein 1 mAbs [3C8](MABL-1197) |
MABL-1197 |
Engineer |
Human |
